Breast cancer screening: closing the gap between science and clinical practice

Breast cancer screening faces a paradox: the science is established, diagnostic tools are robust, and the evidence is conclusive, yet a profound disconnect remains between medical knowledge and the actual clinical actions of patients. Peter Attia identifies that the bottleneck is not research or available imaging technology, but rather the effective communication of individual risk and personalization of screening strategies. This misalignment affects women who lack clarity on when to begin screening, how frequently to screen, and which imaging modality—conventional mammography, ultrasound, or MRI—best fits their risk profile. For readers pursuing preventive longevity, the implication is clear: generic recommendations are insufficient. Instead, an individualized conversation with a clinician integrating age, family history, breast density, and personal risk preferences is essential to construct a truly informed screening strategy.